Return on Equity (ROE)
since 2005
Calculation
Johnson & Johnson, ROE, long-term trends, calculation
| ROE | = | 100 | × | Net earnings1 | ÷ | Shareholders’ equity1 | |
|---|---|---|---|---|---|---|---|
| Dec 31, 2020 | 23.25% | = | 100 | × | 14,714 | ÷ | 63,278 |
| Dec 29, 2019 | 25.42% | = | 100 | × | 15,119 | ÷ | 59,471 |
| Dec 30, 2018 | 25.60% | = | 100 | × | 15,297 | ÷ | 59,752 |
| Dec 31, 2017 | 2.16% | = | 100 | × | 1,300 | ÷ | 60,160 |
| Dec 31, 2016 | 23.49% | = | 100 | × | 16,540 | ÷ | 70,418 |
| Dec 31, 2015 | 21.66% | = | 100 | × | 15,409 | ÷ | 71,150 |
| Dec 28, 2014 | 23.40% | = | 100 | × | 16,323 | ÷ | 69,752 |
| Dec 29, 2013 | 18.68% | = | 100 | × | 13,831 | ÷ | 74,053 |
| Dec 30, 2012 | 16.74% | = | 100 | × | 10,853 | ÷ | 64,826 |
| Dec 31, 2011 | 16.94% | = | 100 | × | 9,672 | ÷ | 57,080 |
| Dec 31, 2010 | 23.57% | = | 100 | × | 13,334 | ÷ | 56,579 |
| Dec 31, 2009 | 24.25% | = | 100 | × | 12,266 | ÷ | 50,588 |
| Dec 28, 2008 | 30.46% | = | 100 | × | 12,949 | ÷ | 42,511 |
| Dec 30, 2007 | 24.41% | = | 100 | × | 10,576 | ÷ | 43,319 |
| Dec 31, 2006 | 28.11% | = | 100 | × | 11,053 | ÷ | 39,318 |
| Dec 31, 2005 | 27.49% | = | 100 | × | 10,411 | ÷ | 37,871 |
Based on: 10-K (filing date: 2021-02-22), 10-K (filing date: 2020-02-18), 10-K (filing date: 2019-02-20), 10-K (filing date: 2018-02-21), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-24), 10-K (filing date: 2014-02-21), 10-K (filing date: 2013-02-22), 10-K (filing date: 2012-02-23), 10-K (filing date: 2011-02-25), 10-K (filing date: 2010-03-01), 10-K (filing date: 2009-02-20), 10-K (filing date: 2008-02-26), 10-K (filing date: 2007-02-21), 10-K (filing date: 2006-03-14).
1 US$ in millions
Comparison to Competitors
Johnson & Johnson, ROE, long-term trends, comparison to competitors
| Johnson & Johnson | Abbott Laboratories | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Eli Lilly & Co. | Gilead Sciences Inc. | Illumina Inc. | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Vertex Pharmaceuticals Inc. | Zoetis Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2020 | 23.25% | 13.71% | 35.30% | 77.20% | -23.84% | 109.79% | 0.68% | 13.98% | 27.91% | 15.21% | 31.86% | 31.22% | 43.46% |
| Dec 29, 2019 | 25.42% | 11.86% | — | 81.07% | 6.66% | 319.09% | 23.91% | 21.72% | 37.99% | 25.77% | 19.08% | 19.34% | 55.39% |
| Dec 30, 2018 | 25.60% | 7.76% | — | 67.15% | 35.07% | 32.88% | 25.51% | 21.98% | 23.30% | 17.59% | 27.91% | 47.28% | 65.35% |
| Dec 31, 2017 | 2.16% | 1.54% | 104.16% | 7.84% | 8.58% | -1.76% | 22.64% | 26.41% | 6.97% | 29.47% | 19.51% | 12.99% | 48.81% |
| Dec 31, 2016 | 23.49% | 6.82% | 128.41% | 25.85% | 27.55% | 19.54% | 71.48% | 21.06% | 9.78% | 12.12% | 20.13% | -9.69% | 55.21% |
| Dec 31, 2015 | 21.66% | 20.85% | 130.39% | 24.71% | 10.97% | 16.53% | 97.70% | 24.97% | 9.94% | 10.75% | 17.40% | -59.19% | 31.74% |
| Dec 28, 2014 | 23.40% | 10.61% | 101.84% | 20.01% | 13.49% | 15.55% | 78.45% | 24.16% | 24.50% | 12.81% | 13.69% | -68.70% | 44.47% |
| Dec 29, 2013 | 18.68% | 10.23% | 91.90% | 23.00% | 16.91% | 26.57% | 27.05% | 8.17% | 8.85% | 28.83% | 21.74% | -32.81% | 53.62% |
| Dec 30, 2012 | 16.74% | 22.32% | 156.85% | 22.80% | 14.39% | 27.69% | 27.84% | 11.47% | 11.63% | 17.93% | 60.24% | -10.71% | 10.83% |
| Dec 31, 2011 | 16.94% | 19.35% | — | 19.35% | 23.25% | 32.11% | 41.60% | 8.06% | 11.50% | 12.18% | -45.65% | 3.76% | — |
| Dec 31, 2010 | 23.57% | 20.66% | — | 19.32% | 19.74% | 40.82% | 49.48% | 10.43% | 1.58% | 9.40% | -19.79% | -149.74% | — |
| Dec 31, 2009 | 24.25% | 25.14% | — | 20.32% | 71.49% | 45.45% | 41.40% | 8.36% | 21.85% | 9.59% | -17.10% | -58.57% | — |
| Dec 28, 2008 | 30.46% | 27.92% | — | 20.58% | 42.86% | -30.76% | 48.43% | 5.95% | 41.63% | 14.08% | -19.75% | -192.51% | — |
| Dec 30, 2007 | 24.41% | 20.28% | — | 17.72% | 20.50% | 21.61% | 46.69% | -67.62% | 18.01% | 12.53% | -22.94% | -144.23% | — |
| Dec 31, 2006 | 28.11% | 12.22% | — | 15.56% | 15.86% | 24.25% | -65.54% | 16.16% | 25.25% | 27.10% | -47.24% | -40.89% | — |
| Dec 31, 2005 | 27.49% | 23.39% | — | 17.96% | 26.77% | 18.34% | 26.88% | -28.79% | 25.85% | 12.32% | -83.72% | -85.05% | — |
Based on: 10-K (filing date: 2021-02-22), 10-K (filing date: 2020-02-18), 10-K (filing date: 2019-02-20), 10-K (filing date: 2018-02-21), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-24), 10-K (filing date: 2014-02-21), 10-K (filing date: 2013-02-22), 10-K (filing date: 2012-02-23), 10-K (filing date: 2011-02-25), 10-K (filing date: 2010-03-01), 10-K (filing date: 2009-02-20), 10-K (filing date: 2008-02-26), 10-K (filing date: 2007-02-21), 10-K (filing date: 2006-03-14).
Comparison to Sector (Pharmaceuticals & Biotechnology)
Johnson & Johnson, ROE, long-term trends, comparison to sector (pharmaceuticals & biotechnology)
| Johnson & Johnson | Pharmaceuticals & Biotechnology | |
|---|---|---|
| Dec 31, 2020 | 23.25% | 18.05% |
| Dec 29, 2019 | 25.42% | 29.60% |
| Dec 30, 2018 | 25.60% | 27.94% |
| Dec 31, 2017 | 2.16% | 14.50% |
| Dec 31, 2016 | 23.49% | 23.11% |
| Dec 31, 2015 | 21.66% | 22.96% |
| Dec 28, 2014 | 23.40% | 21.88% |
| Dec 29, 2013 | 18.68% | 20.86% |
| Dec 30, 2012 | 16.74% | 19.43% |
| Dec 31, 2011 | 16.94% | 16.36% |
| Dec 31, 2010 | 23.57% | 14.94% |
| Dec 31, 2009 | 24.25% | 21.95% |
| Dec 28, 2008 | 30.46% | 23.51% |
| Dec 30, 2007 | 24.41% | 18.18% |
| Dec 31, 2006 | 28.11% | 22.85% |
| Dec 31, 2005 | 27.49% | 19.61% |
Based on: 10-K (filing date: 2021-02-22), 10-K (filing date: 2020-02-18), 10-K (filing date: 2019-02-20), 10-K (filing date: 2018-02-21), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-24), 10-K (filing date: 2014-02-21), 10-K (filing date: 2013-02-22), 10-K (filing date: 2012-02-23), 10-K (filing date: 2011-02-25), 10-K (filing date: 2010-03-01), 10-K (filing date: 2009-02-20), 10-K (filing date: 2008-02-26), 10-K (filing date: 2007-02-21), 10-K (filing date: 2006-03-14).
Comparison to Industry (Health Care)
Johnson & Johnson, ROE, long-term trends, comparison to industry (health care)
| Johnson & Johnson | Health Care | |
|---|---|---|
| Dec 31, 2020 | 23.25% | 15.90% |
| Dec 29, 2019 | 25.42% | 23.37% |
| Dec 30, 2018 | 25.60% | 21.29% |
| Dec 31, 2017 | 2.16% | 13.56% |
| Dec 31, 2016 | 23.49% | 18.84% |
| Dec 31, 2015 | 21.66% | 18.48% |
| Dec 28, 2014 | 23.40% | 19.31% |
| Dec 29, 2013 | 18.68% | 18.98% |
| Dec 30, 2012 | 16.74% | 17.23% |
| Dec 31, 2011 | 16.94% | 15.96% |
| Dec 31, 2010 | 23.57% | 14.48% |
| Dec 31, 2009 | 24.25% | 19.23% |
| Dec 28, 2008 | 30.46% | 19.21% |
| Dec 30, 2007 | 24.41% | 16.90% |
| Dec 31, 2006 | 28.11% | 18.60% |
| Dec 31, 2005 | 27.49% | 19.18% |
Based on: 10-K (filing date: 2021-02-22), 10-K (filing date: 2020-02-18), 10-K (filing date: 2019-02-20), 10-K (filing date: 2018-02-21), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-24), 10-K (filing date: 2014-02-21), 10-K (filing date: 2013-02-22), 10-K (filing date: 2012-02-23), 10-K (filing date: 2011-02-25), 10-K (filing date: 2010-03-01), 10-K (filing date: 2009-02-20), 10-K (filing date: 2008-02-26), 10-K (filing date: 2007-02-21), 10-K (filing date: 2006-03-14).